HomeCompareMCVEF vs EPRT

MCVEF vs EPRT: Dividend Comparison 2026

MCVEF yields 0.62% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPRT wins by $42.8K in total portfolio value
10 years
MCVEF
MCVEF
● Live price
0.62%
Share price
$27.25
Annual div
$0.17
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$64.97
Full MCVEF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — MCVEF vs EPRT

📍 EPRT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCVEFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCVEF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCVEF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCVEF
Annual income on $10K today (after 15% tax)
$53.03/yr
After 10yr DRIP, annual income (after tax)
$55.22/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, EPRT beats the other by $10,859.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCVEF + EPRT for your $10,000?

MCVEF: 50%EPRT: 50%
100% EPRT50/50100% MCVEF
Portfolio after 10yr
$42.0K
Annual income
$6,452.84/yr
Blended yield
15.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

MCVEF
No analyst data
Altman Z
2.3
Piotroski
6/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCVEF buys
0
EPRT buys
0
No recent congressional trades found for MCVEF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCVEFEPRT
Forward yield0.62%3.92%
Annual dividend / share$0.17$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$20.6K$63.4K
Annual income after 10y$64.97$12,840.73
Total dividends collected$638.00$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MCVEF vs EPRT ($10,000, DRIP)

YearMCVEF PortfolioMCVEF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$10,762$62.39$11,205$505.18$443.00EPRT
2$11,579$62.75$12,672$682.46$1.1KEPRT
3$12,452$63.09$14,490$930.48$2.0KEPRT
4$13,387$63.41$16,786$1,282.69$3.4KEPRT
5$14,388$63.71$19,753$1,791.56$5.4KEPRT
6$15,459$64.00$23,677$2,541.64$8.2KEPRT
7$16,606$64.26$29,008$3,672.99$12.4KEPRT
8$17,832$64.51$36,463$5,425.08$18.6KEPRT
9$19,145$64.75$47,238$8,221.57$28.1KEPRT
10$20,551$64.97$63,385$12,840.73$42.8KEPRT

MCVEF vs EPRT: Complete Analysis 2026

MCVEFStock

Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. The company operates 97 clinical laboratories, 733 blood-drawing points, and 26 clinics in 10 countries; and 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. It serves corporate and private customers, and patients, as well as public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Full MCVEF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this MCVEF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCVEF vs SCHDMCVEF vs JEPIMCVEF vs OMCVEF vs KOMCVEF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.